{"transactions":[{"id":4636929,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-10-07T20:02:44.000Z","date":"2026-10-05","kind":"sale","planned":false,"acquired":false,"shares":325,"price":4.39,"value":1426.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person."}],"balance_after":127994,"source":{"system":"sec-edgar","filing":"0001628280-26-065325","document":"wk-form4_1791403362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026065325/wk-form4_1791403362.xml","form_type":"4"}},{"id":721495,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:02:47.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":561,"price":3.87,"value":2171.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":128319,"source":{"system":"sec-edgar","filing":"0001628280-26-046507","document":"wk-form4_1782936164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046507/wk-form4_1782936164.xml","form_type":"4"}},{"id":721494,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:01:45.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":449,"price":4.38,"value":1966.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":131758,"source":{"system":"sec-edgar","filing":"0001628280-26-046501","document":"wk-form5_1782936102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046501/wk-form5_1782936102.xml","form_type":"5"}},{"id":721493,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:01:45.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":930,"price":4.23,"value":3933.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":71309,"source":{"system":"sec-edgar","filing":"0001628280-26-046501","document":"wk-form5_1782936102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046501/wk-form5_1782936102.xml","form_type":"5"}},{"id":721492,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:01:45.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":999,"price":4.26,"value":4255.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":35404,"source":{"system":"sec-edgar","filing":"0001628280-26-046501","document":"wk-form5_1782936102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046501/wk-form5_1782936102.xml","form_type":"5"}},{"id":721491,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-01T20:01:45.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":279,"price":4.69,"value":1308.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":27530,"source":{"system":"sec-edgar","filing":"0001628280-26-046501","document":"wk-form5_1782936102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026046501/wk-form5_1782936102.xml","form_type":"5"}},{"id":772500,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-19T20:08:09.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":543,"price":2.67,"value":1449.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. This transaction does not represent a discretionary sale by the Reporting Person."}],"balance_after":125101,"source":{"system":"sec-edgar","filing":"0001628280-26-036427","document":"wk-form4_1779221287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026036427/wk-form4_1779221287.xml","form_type":"4"}},{"id":832483,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:41.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":419,"price":4.12,"value":1726.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":110397,"source":{"system":"sec-edgar","filing":"0001628280-26-020188","document":"wk-form4_1774038338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026020188/wk-form4_1774038338.xml","form_type":"4"}},{"id":832482,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:41.000Z","date":"2026-03-12","kind":"sale","planned":false,"acquired":false,"shares":1589,"price":4.09,"value":6499.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":110816,"source":{"system":"sec-edgar","filing":"0001628280-26-020188","document":"wk-form4_1774038338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026020188/wk-form4_1774038338.xml","form_type":"4"}},{"id":832481,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:25:41.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":1449,"price":4.13,"value":5984.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person."}],"balance_after":112405,"source":{"system":"sec-edgar","filing":"0001628280-26-020188","document":"wk-form4_1774038338.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000162828026020188/wk-form4_1774038338.xml","form_type":"4"}},{"id":988873,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-25T20:42:15.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date."}],"balance_after":408937,"derivative":{"exercise_price":5.55,"expiration_date":"2035-11-23","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001982638-25-000004","document":"wk-form4_1764103333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000198263825000004/wk-form4_1764103333.xml","form_type":"4"}},{"id":988872,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-11-25T20:42:15.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date."}],"balance_after":113854,"source":{"system":"sec-edgar","filing":"0001982638-25-000004","document":"wk-form4_1764103333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000198263825000004/wk-form4_1764103333.xml","form_type":"4"}},{"id":1139198,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T21:30:33.000Z","date":"2025-05-19","kind":"sale","planned":false,"acquired":false,"shares":6597,"price":5.18,"value":34172.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of the shares was to cover the tax liability associated with the granted RSUs."}],"balance_after":69101,"source":{"system":"sec-edgar","filing":"0001826667-25-000057","document":"wk-form4_1747863026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000182666725000057/wk-form4_1747863026.xml","form_type":"4"}},{"id":1139197,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-21T21:30:33.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":21428,"price":5.18,"value":110997.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The granted RSUs vest immediately."}],"balance_after":75698,"source":{"system":"sec-edgar","filing":"0001826667-25-000057","document":"wk-form4_1747863026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000182666725000057/wk-form4_1747863026.xml","form_type":"4"}},{"id":1260584,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-19T22:43:23.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":7644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. 12.5% of the shares subject to the RSU Award shall vest on the grant date of February 18, 2025; 25% of the shares subject to the RSU Award shall vest on each of May 15, 2025, August 15, 2025, and November 14, 2025; and the remaining shares subject to the RSU Award will vest on February 13, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":54270,"source":{"system":"sec-edgar","filing":"0001415889-25-004684","document":"form4-02192025_100219.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000141588925004684/form4-02192025_100219.xml","form_type":"4"}},{"id":1292023,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-29T22:58:37.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."}],"balance_after":75000,"derivative":{"exercise_price":5.3,"expiration_date":"2035-01-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001415889-25-002284","document":"form4-01292025_100134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000141588925002284/form4-01292025_100134.xml","form_type":"4"}},{"id":1292022,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-29T22:58:37.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":46626,"source":{"system":"sec-edgar","filing":"0001415889-25-002284","document":"form4-01292025_100134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000141588925002284/form4-01292025_100134.xml","form_type":"4"}},{"id":1364034,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR.VP, CORP. DEV. & STRATEGY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-11-16T00:00:49.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":41250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 14, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date."}],"balance_after":41250,"derivative":{"exercise_price":4.01,"expiration_date":"2034-11-13","underlying":"Common Stock","underlying_shares":41250},"source":{"system":"sec-edgar","filing":"0001415889-24-026999","document":"form4-11162024_121145.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000141588924026999/form4-11162024_121145.xml","form_type":"4"}},{"id":1364033,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR.VP, CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-11-16T00:00:49.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":6875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 14, 2024, subject to the Reporting Person's continuous service with the Issuer on each such date."}],"balance_after":34126,"source":{"system":"sec-edgar","filing":"0001415889-24-026999","document":"form4-11162024_121145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000141588924026999/form4-11162024_121145.xml","form_type":"4"}},{"id":1643543,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR.VP, CORP. DEV. & STRATEGY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-14T23:42:18.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":63750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of February 12, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":63750,"derivative":{"exercise_price":9.5,"expiration_date":"2034-02-11","underlying":"Common Stock","underlying_shares":63750},"source":{"system":"sec-edgar","filing":"0001415889-24-003817","document":"form4-02142024_110206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000141588924003817/form4-02142024_110206.xml","form_type":"4"}},{"id":1643542,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR.VP, CORP. DEV. & STRATEGY"}}],"security":"Common Stock","published_at":"2024-02-14T23:42:18.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":14752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on February 12, 2024, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":27251,"source":{"system":"sec-edgar","filing":"0001415889-24-003817","document":"form4-02142024_110206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000141588924003817/form4-02142024_110206.xml","form_type":"4"}},{"id":1671124,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SR.VP, CORP. DEV. & STRATEGY"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-25T22:43:31.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of January 24, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":40000,"derivative":{"exercise_price":9.28,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-001819","document":"form4-01252024_100125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000141588924001819/form4-01252024_100125.xml","form_type":"4"}},{"id":1808796,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":34077,"kind":"person","name":"Marshak Richard","position":1,"cik":"0001982638","reported_name":"Marshak Richard","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr.VP, Corp. Dev. & Strategy"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-14T23:18:12.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of August 10, 2023, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":40000,"derivative":{"exercise_price":12,"expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-045725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1982638/000120919123045725/doc4.xml","form_type":"4"}}]}